QNTM
NASDAQ · Pharmaceuticals
Quantum Biopharma-B Sub Vot
$3.53
+0.30 (+9.29%)
Open$3.30
Previous Close$3.23
Day High$3.71
Day Low$3.22
52W High$43.00
52W Low$2.85
Volume—
Avg Volume10.5K
Market Cap28.15M
P/E Ratio—
EPS$-8.27
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+168.6% upside
Current
$3.53
$3.53
Target
$9.48
$9.48
$6.03
$9.48 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.34M | 7.61M | 6.92M |
| Net Income | -63,534,033 | 1.84M | 1.19M |
| Profit Margin | -19,353.5% | 24.2% | 17.2% |
| EBITDA | -39,330,326 | 2.64M | 2.30M |
| Free Cash Flow | — | 1.03M | 1.07M |
| Rev Growth | — | +16.6% | +5.5% |
| Debt/Equity | 0.02 | 0.64 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |